Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Litigation Details for Lucent Technologies, Inc. v. Gateway, Inc. (S.D. Cal. 2007)

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Lucent Technologies, Inc. v. Gateway, Inc. (S.D. Cal. 2007)

Docket   Start Trial Date Filed 2007-10-16
Court District Court, S.D. California Date Terminated 2012-01-17
Cause 28:1338pt Patent Infringement Assigned To Marilyn L. Huff
Jury Demand Defendant Referred To Cathy Ann Bencivengo
Patents 10,046,056; 4,616,006; 7,202,031; 9,108,002; 9,109,010
Attorneys Alan D Albright; Ali R Sharifahmadian; Alison Priske Adema; Brian M. Rostocki; Bryan D. Atkinson; Carter Glasgow Phillips; Cathy L. Reese; Cecil E Key; Christopher Scott Marchese; Constantine L. Trela; David A Hahn; David Jordan Zubkoff; Edward C. Donovan; Elizabeth T Bernard; Eric D Hayes; Francis Albert; Gregory A Madera; Gregory F Corbett; Howard D Shatz; James E Marina; James S Blackburn; Jane Hahn; Jeanne M Heffernan; Jeffrey B Plies; Jennifer J. Schmidt; John Bustamante; John E Gartman; John E Giust; John L. Newby; John M Desmarais; John M Skenyon; John W Thornburgh; Jonas Reale McDavit; Jonathan D Baker; Jordan N Malz; Joseph A Micallef; Juanita R Brooks; Karen Michelle Robinson; Katherine Farkas; Kelly C Hunsaker; Kenneth H Bridges; Kenneth Howard Bridges; Kurt L Glitzenstein; Lara Sue Garner; Matthew Bathon; Matthew C Bernstein; Michael A. Oakes; Michael E. Florey; Michael Lavine; Michael P Stadnick; Monica P. Sekhon; Owais Ahmed Siddiqui; Paul A Bondor; Renee Skinner; Richard M Koehl; Robert A Appleby; Robert D Rhoad; Ryan Kane; Shekhar Vyas; Steven Robert Daniels; Thomas Goldstein; Thomas M Melsheimer
Firms David A. Hahn, Attorney at Law; Fish & Richardson PC; Hahn and Adema; Kirkland & Ellis LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Lucent Technologies, Inc. v. Gateway, Inc.
Biologic Drugs cited in Lucent Technologies, Inc. v. Gateway, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Lucent Technologies, Inc. v. Gateway, Inc. (S.D. Cal. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-12-14 148 Exhibit 1 to Marina Declaration :9 106:20 44:24 102:20 103:9 108:2,5 121:9 spoke (2) 88:3 …of Invalidity of Claims 1-3 of the Fleming '759 Patent by Plaintiff Lucent Technologies, Inc.. (Attachments… 7 Q Do you know if that case was also a patent 7 A No. 8 infringement lawsuit?… 113:18 38:4,6 50:18 51:19 patent (1) 129:20 130:1 68:…2007 17 January 2012 3:07-cv-02000 830 Patent Defendant District Court, S.D External link to document
2007-12-21 181 Exhibit 20 cancelled -- it‘s, I believe you said, from higher up 10:46:56 2 0 A. l don't know wha -- 2 1 in management…U.S. Patent No. 4,763,356 (Day) MOTION for Partial Summary Judgment of Invalidity of U.S. Patent No. 4,763,356…linked to the patents, like I say, I 09:43: 12 § 9 Exhibit 2. 09:39:37 9 only had the patent itself, no …:00 6 patent No. 4,763,356, entitled "Touch Screen Forrn 10:15:13 6 related to this patent? 10:18… 10:18:09 1 1 A. That's my patent. 10:15:31 1 1 led to this patent? 10:18:11 1 2 Q. You indicated External link to document
2008-01-14 259 Notice Regarding Exhibit Attachment FY5 2006 'l'arge't § Actu'al 5.4 616 6.3 4-.8`:"1?.1 Di`s`cussio'n: Target met…proportions, Patent_ pendency -- the amount of time a patent application is waiting before a patent -is issued…of the Patent organization is the examination of an inventor’s application for a patent. Patent examiners…rformaijce, Méasures Patent A|l'owance Er"TOr' RH_iE 4..0% Patent |n-Process.Examina_`iipn…S"CA:l_ YEAR 2006 LEAD|NG WlTH PATENTS Our Patent organization broke virtually every record External link to document
2008-01-14 262 Notice Regarding Exhibit Attachment :ng data 226 2315 22.7 330.8 3014 16.4 21.7 202 31 _1 344 32.-1 v1110 429 254 296 232 …Summary of Patent Examining A¢tiv'ities` 120 Table 2 Patent Apphcations Filed 121 Ta ble 3 Patent`App|ications…122 Ta ble 4 Patent Pendency St`atistics' 123 Table 5 Summary of Tota| Pendihg Patent-App[iéafiohs…iéafiohs' 124 Table 6 Patents |ssued v 125-l Table 7 Patent Applications Fil'ed by Re'sidents'… EXHIBIT 117D by Multimedia Patent Trust, Lucent Technologies, Inc. re 243 Declaration (Attachments External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.